INVO Fertility Stock (NASDAQ:IVF)

Revenue Financials Chart

Previous Close

$0.95

52W Range

$0.71 - $103.97

50D Avg

$1.09

200D Avg

$11.46

Market Cap

$219.86K

Avg Vol (3M)

$7.50M

Beta

2.67

Div Yield

-

IVF Company Profile

INVO Fertility, Inc. operates as a revenue-generating fertility business. It also focuses on the development of class clinical-stage assets in oncology and autoimmune diseases. The company was founded on January 5, 2007 and is headquartered in Sarasota, FL.

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

30

IPO Date

Nov 02, 2020

Website

IVF Performance

IVF Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	$6.53M	$3.02M	$822.20K
Operating Income	$-8.13M	$-6.77M	$-10.63M
Net Income	$-9.10M	$-8.03M	$-10.89M
EBITDA	$-7.14M	$-6.88M	$-10.75M
Basic EPS	$-30.19	$-5.13	$-8.99
Diluted EPS	$-30.19	$-5.13	$-8.99

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts

Q2 23Aug 14, 23 | 10:50 PM

Q1 23May 15, 23 | 8:05 PM

Q4 22Apr 17, 23 | 7:01 PM

Peer Comparison

Ticker	Company
CUTR	Cutera, Inc.
AXDX	Accelerate Diagnostics, Inc.